Carlsmed, Inc. Total Assets
Carlsmed, Inc. total assets. Based on the latest financial reports, Carlsmed, Inc. (CARL) holds total assets worth $118.20 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Carlsmed, Inc. market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of Carlsmed, Inc. (2023–2025)
Total assets of Carlsmed, Inc. from 2023 to 2025. This chart illustrates how Carlsmed, Inc.'s total assets have evolved over time, based on quarterly financial data. See today's stock price for Carlsmed, Inc. for real-time trading data and today's change.
Carlsmed, Inc. - Asset Composition Analysis
Carlsmed, Inc. Total Assets Breakdown (December 2025)
Carlsmed, Inc. total assets breakdown as of December 2025. Carlsmed, Inc.'s total assets of $118.20 Million consist of 97.4% current assets and 2.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 65.9% |
| Accounts Receivable | $11.36 Million | 8.7% |
| Inventory | $1.84 Million | 1.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how Carlsmed, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Carlsmed, Inc. (CARL) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Carlsmed, Inc.'s current assets represent 97.4% of total assets in 2025, an increase from 83.9% in 2023.
- Cash Position: Cash and equivalents constituted 65.9% of total assets in 2025, up from 51.5% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is accounts receivable at 8.7% of total assets.
Carlsmed, Inc. Competitors by Total Assets
Key competitors of Carlsmed, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hinge Health, Inc.
NYSE:HNGE
|
USA | $827.40 Million |
|
Kneat.com Inc
TO:KSI
|
Canada | CA$121.76 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
|
Singular Health Group Ltd
AU:SHG
|
Australia | AU$12.55 Million |
|
Medadvisor Ltd
AU:MDR
|
Australia | AU$39.84 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$16.53 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
Carlsmed, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.84 | 4.87 | 1.58 |
| Quick Ratio | 8.66 | 4.76 | 1.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $97.20 Million | $36.71 Million | $4.33 Million |
Carlsmed, Inc. - Advanced Valuation Insights
This section examines the relationship between Carlsmed, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.94 |
| Latest Market Cap to Assets Ratio | 3.14 |
| Asset Growth Rate (YoY) | 151.1% |
| Total Assets | $130.12 Million |
| Market Capitalization | $408.18 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Carlsmed, Inc.'s assets at a significant premium (3.14x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Carlsmed, Inc.'s assets grew by 151.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Carlsmed, Inc. (2023–2025)
The table below shows the annual total assets of Carlsmed, Inc. from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $130.12 Million | +151.08% |
| 2024-12-31 | $51.82 Million | +269.54% |
| 2023-12-31 | $14.02 Million | -- |
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more